Latest Macular degeneration Stories
Professor Eberhart Zrenner Discusses the Future of Artificial Vision at Premier International Ophthalmology Meeting PARIS, June 30, 2014 /PRNewswire/ --
TARRYTOWN, N.Y., June 27, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
First population-based study to show that environmental factors may outweigh genetics in myopia development; researchers suggest students should spend time outdoors SAN FRANCISCO, June 26,
MENLO PARK, Calif., June 24, 2014 /PRNewswire/ -- ForSight VISION5 is pleased to announce that Charles Semba, MD has joined the company as Chief Medical Officer from Shire Pharmaceuticals where
Foundation Fighting Blindness Co-Founder and Chairman Gordon Gund and Family to Catalyze Retinal Degenerative Disease Research with Unlimited Donation Matching Challenge for Two Years
SOPHIA ANTIPOLIS, France, and SAN DIEGO, June 19, 2014 /PRNewswire/ -- Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, and Sequenom, Inc.
Ophthalmologist Michael Tracy, MD of Carlsbad Eye Care describes new findings on potential eye dangers. San Diego, CA (PRWEB) June 12, 2014
TARRYTOWN, N.Y., June 11, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
SEATTLE, June 9, 2014 /PRNewswire/ -- LumiThera Inc., a medical device company focused on the development of non-invasive light emitting diode (LED) treatments for ocular disorders and disease,
VANCOUVER, June 9, 2014 /PRNewswire/ - iCo Therapeutics Inc.
- In medieval musical notation, a sign or neume denoting a shake or trill.